Recall Register

Food, drugs, devices › Magellan Diagnostics, Inc.

Device recall: The LeadCare¿ II Blood Lead Test System relies on electrochemistry and a unique Sensor to detect lead in whole blood. Th

FDA enforcement event 97858 · Class II · initiated 23 Feb 2024 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordNorth Billerica, MA

Magellan Diagnostics, Inc. (North Billerica, MA) initiated this device recall on 23 Feb 2024; FDA lists 1 product record under event 97858, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 970 device enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Magellan Diagnostics, Inc. has 9 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Magellan Diagnostics, Inc., North Billerica, MA.

Reason for recall

"Calibration Buttons being used in the kitting process were incorrectly labeled as Lot 2323M for lot 2333M. The use of mislabeled calibration Button with Lot #2333 can lead to delayed or erroneous high or erroneous low results."

Distribution

"US Nationwide distribution."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0584-2026The LeadCare¿ II Blood Lead Test System relies on electrochemistry and a unique Sensor to detect lead in whole blood. The LeadCare¿ II Test Kit is provided with the following materials: " Sensors (2 Containers of 24 sensors each; 48 tests) " Treatment Reagent Tubes (2 packages of 24 tubes each; 48 tests) "…1,774 unitsClass IIOngoing3 Dec 2025

Context

87%of 2024 device events are Class II970 events that year
1product record in this eventfirm median: 2
9events on this register for the firm

Other enforcement events for Magellan Diagnostics, Inc.

InitiatedProduct (first record)TypeClassRecords
13 Mar 2026(1)(2) LeadCare¿ II Blood Lead Test Kit, (3)LeadCare¿ II 5X Blood Lead Test Kit, (4)LeadCare¿ II 9X Blood Lead Test Kit DeviceClass II3
19 Sep 2023LeadCare II Blood Lead Test Kit-For in vitro diagnostic use only. The test kit is for the quantitative measurement of leDeviceClass II1
7 May 2021LeadCare II Blood Lead Test Kit Catalog Number 70-6762DeviceClass I3
8 Aug 2018Magellan LeadCare¿ II Blood Lead Test Kit. In Vitro Test for the measurement of lead in fresh whole blood. Catalog NumbeDeviceClass II1
9 Jan 2018LeadCare II Blood Lead Analyzer Part Numbers: 70-6760, 70-6529-R, 70-6760-P, 70-6760-R. Intended for in vitro (external)DeviceClass II2
23 May 2017Magellan Diagnostics LeadCare and LeadCare II test Kits. Product Usage: The LeadCare Blood Lead Test Kit is for in vitroDeviceClass I2
20 Jan 2016LeadCare II Blood Lead Test Kit, containing LeadCare II Lead Controls Product Usage: IVD test kit for the detection of lDeviceClass II1
29 Nov 2014Magellan Diagnostics LeadCare Ultra Blood Analyzer Part Number: 80-0010DeviceClass I2

All 9 events for Magellan Diagnostics, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Calibration Buttons being used in the kitting process were incorrectly labeled as Lot 2323M for lot 2333M. The use of mislabeled calibration Button with Lot #2333 can lead to delayed or erroneous high or erroneous low results."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide distribution."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.